(Press-News.org) (Paris, France, Wednesday, 17 September 2025) A new international study presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that adults with atopic eczema (AE) are significantly more likely to experience suicidal thoughts, with researchers uncovering the key factors driving this elevated risk.1
As one of the largest global investigations to examine the link between AE and suicidal ideation, the “Scars of Life” study surveyed 30,801 adults across 27 countries in 2024. Among them, 15,223 were adults with physician-confirmed current AE, while 7,968 adults without AE served as controls.
Participants with current AE were grouped by age of AE onset – childhood, adolescence, or adulthood – and completed a detailed online questionnaire capturing sociodemographic information, self-reported suicidal ideation, severity of itch and skin pain, AE severity, and experiences of skin-related stigmatisation.
The results showed that 13.2% of adults with AE reported suicidal ideation, compared with 8.5% of adults without AE. All AE subgroups – whether the condition began in childhood, adolescence, or adulthood – had higher odds of suicidal ideation than controls, highlighting the widespread mental health burden of the condition.
Atopic eczema, a chronic inflammatory skin condition affecting more than 200 million people worldwide, is characterised by recurring episodes of dry, itchy and inflamed skin.2,3 Beyond the physical symptoms, its impact on mental health is increasingly recognised, with many experiencing anxiety, depression, and social stigma, alongside the daily challenges of managing their condition.4
Importantly, the study identified several factors strongly associated with suicidal ideation in adults with AE. Younger adults, particularly those under 30, were more likely to report suicidal thoughts (OR=1.6), as were individuals with obesity (OR=1.29).
Clinical features also played a major role: moderate-to-severe AE doubled the odds of suicidal ideation (OR=2.01), while pruritus (itching), skin pain, and high overall symptom intensity were all significantly associated with increased risk.
Psychosocial and sleep factors further contributed to risk. Adults with suicidal thoughts reported higher levels of stigmatisation and more prevalent sleep disorders, with mixed insomnia – difficulty falling and staying asleep – notably linked to suicidal ideation (OR=1.78).
Dr Delphine Kerob, one of the lead researchers, commented, “These findings reveal a critical insight from our large-scale study, which seeks to uncover the hidden, long-term impact of living with common inflammatory skin conditions such as atopic eczema.”
“The results highlight that the effects of atopic eczema are more than skin deep, with suicidal thoughts representing a serious and frequent concern that is often overlooked by healthcare professionals,” she continued. “By identifying the main risk factors behind suicidal ideation in this population, we hope this study will help healthcare professionals better recognise and address these challenges, supporting patients’ overall well-being more effectively.”
Discussing the next steps for research, Dr Kerob said, “Looking ahead, we are investigating why suicidal ideation occurs at different rates across countries, which may reflect important cultural differences. At the same time, ongoing analyses from the “Scars of Life” study are enhancing our understanding of what happens beneath the surface in patients with atopic eczema.”
END
Note to editors:
A reference to the EADV Congress 2025 must be included in all coverage and/or articles associated with this study.
For more information or to arrange an expert interview, please contact press@eadv.org.
About the study author:
Dr Delphine Kerob is a Dermatologist with a degree in Oncology Radiation Therapy and a Master in Clinical Pharmacology. Dr Kerob is a consultant dermatologist at Saint Louis hospital in Paris, specialised in oncodermatology. She is also the Scientific Director of La Roche-Posay Laboratoire Dermatologique
About the “Scars of Life” study:
The "Scars of Life" study has been conducted by La Roche-Posay Laboratoire Dermatologique in collaboration with international experts in atopic dermatitis, with Professor Jonathan Silverberg serving as the lead expert, as well in collaboration with multiple patient associations. This cross-sectional observational study was conducted between June and September 2024, involving 30,801 adults from 27 countries across five continents. This project aimed to create a comprehensive international database to evaluate the psychosocial burden of AE.
About EADV:
Founded in 1987, EADV is a non-profit organisation with a vision to form a premier European Dermatology-Venereology Society. The Academy counts over 12,000 members from all around the globe, providing a valuable service for every type of dermatologist-venereologist professional. The EADV is dedicated to advancing patient care, education and research by providing a unique platform to bring people together and share ideas.
This year, the EADV Congress will take place in Paris, France, and online from 17-20 September 2025. Find out more: https://eadv.org/congress/
References:
Seneschal, J., Halioua, B., Tan, J., Gu, C., Luger, T., Dodiuk-Gad, R., Takaoka, R., Aslanian, F., Prakoeswa, C. R. S., Demessant-Flavigny, A.-L., Lefloch, C., Kerrouche, N., Merhand, S., Smith Begolka, W., Luca de Tena, Á., Burstein, S., Kerob, D., Taieb, C., Skayem, C., Kelbore, A. G., Misery, L., Tempark, T., Stratigos, A., Steinhoff, M., & Silverberg, J. I. (2025). Prevalence and risk factors of suicidal ideation in atopic eczema: Insights from the Scars of Life study. Presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025.
NHS. (2024). Atopic eczema. https://www.nhs.uk/conditions/atopic-eczema/
Chovatiya R. (2023). Atopic Dermatitis (Eczema). JAMA, 329(3), 268. https://doi.org/10.1001/jama.2022.21457
Schonmann, Y., Mansfield, K. E., Hayes, J. F., Abuabara, K., Roberts, A., Smeeth, L., & Langan, S. M. (2020). Atopic eczema in adulthood and risk of depression and anxiety: A population-based cohort study. The Journal of Allergy and Clinical Immunology: In Practice, 8(1), 248–257.e16. https://doi.org/10.1016/j.jaip.2019.08.030 END
Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce atherosclerosis development in adults with obesity—a leading underlying cause of cardiovascular disease.
The study of adults with obesity but not diabetes is by researchers from the University of Copenhagen, Denmark, and is presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna ...
Guideline development and inclusiveness
The guideline was developed in line with internationally recognised standards, including the GRADE methodology and the RIGHT reporting statement, and reflects the EASD’s newly established Standard Operating Procedures for guideline development. Importantly, people with lived experience of type 1 diabetes and type 2 diabetes were active members of the Guideline Development Panel from the outset. Their contributions helped shape the clinical questions, interpretation of evidence, and formulation of recommendations, ensuring that the final guideline is firmly ...
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in the journal Pharmaceutics.
GLP-1 drugs such as semaglutide are widely used to treat type 2 diabetes and obesity. They do this by mimicking the action of GLP-1, a hormone that helps the body make more insulin when needed, slows down digestion, curbs appetite and increases feelings of fullness.
Many tissues around the body have GLP-1 receptors (proteins ...
New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15-19) and simultaneously published in NEJM shows that daily treatment with the new once-daily GLP-1 agonist orforglipron results in substantial weight loss in people living with obesity that do not have type 2 diabetes. The study is by Dr Sean Wharton, McMaster University, Hamilton, ON, Canada and Wharton Weight Management Clinic, Burlington, ON, Canada, and colleagues. The study is sponsored by Eli Lilly, the manufacturer of orforglipron.
Orforglipron is a small-molecule, ...
URBANA, Ill. – Genes are the building blocks of life, and the genetic code provides the instructions for the complex processes that make organisms function. But how and why did it come to be the way it is? A recent study from the University of Illinois Urbana-Champaign sheds new light on the origin and evolution of the genetic code, providing valuable insights for genetic engineering and bioinformatics.
“We find the origin of the genetic code mysteriously linked to the dipeptide composition of a proteome, the collective of proteins in an organism,” said corresponding author Gustavo Caetano-Anollés, professor in the Department ...
Key points
State and local officials in Florida maintain hundreds coops with what are referred to as sentinel chickens, which act as an early alarm system for the presence of mosquito-borne illnesses in an area. This alarm system just got an upgrade.
An interdisciplinary team of experts, including a zoonotic disease specialist, a museum data scientist and a salamander biologist, have combined their skills and created a statistical model that accurately predicts the activity of West Nile virus in an area up to six months in advance.
The model was trained using two decades of sentinel chicken data. The original data files ...
A new study illuminates how some areas of the country have been hit much harder than others by the fentanyl epidemic, which took more than 70,800 lives in 2022 alone.
The research calls attention to a need for focused, coordinated efforts to prevent overdose deaths in the places where deaths from the opioid are rampant, said lead author Thomas Wickizer, a professor emeritus in The Ohio State University College of Public Health.
The study appears in the journal Health Affairs Scholar.
“We can look at this map and see there are certain areas which are experiencing this at an extremely dire rate, and energy and resources, including financial investments, should ...
One of the main factors driving prices in pharmaceuticals, such as cholesterol-lowering drugs and antibiotics, is the cost of production and materials. Researchers at the University of Maine Forest Bioproducts Research Institute (FBRI) have discovered a sustainable method to produce the key ingredient in a broad range of pharmaceuticals, which could help address high prescription drug costs in the U.S.
Among some of the most expensive medications are those that require a chiral center ― a property in which a molecule cannot be superimposed with its mirror image, like right and ...
Aging, neurological diseases and our bodies’ stress response are all linked to the tiny power plants inside each cell known as mitochondria. To function properly, mitochondria must first read instructions from their DNA and then copy it over into mRNA in a process called transcription. Now, researchers at Thomas Jefferson University have reconstructed transcription in human mitochondria in unprecedented detail. The findings, published in Molecular Cell, show how the molecular machinery works and reveal potential drug targets for mitochondrial diseases.
“When we understand ...
In a new study conducted at the University of Hawaiʻi at Mānoa, researchers from the John A. Burns School of Medicine (JABSOM) have shown that the loss of a key male fertility gene leads to infertility and changes expression of hundreds of other important genes.
The study was led by Professor Dr. Monika Ward from the Department of Anatomy, Biochemistry & Physiology and the Yanagimachi Institute for Biogenesis Research (YIBR). The team has been investigating a zinc finger Y-encoded gene called Zfy. This gene, encoded on Y chromosome in both mice and humans, is considered a male fertility factor. In mice, Zfy is present as two copies, Zfy1 and Zfy2.
The researchers ...
